ClinVar Miner

Submissions for variant NM_000540.3(RYR1):c.3964_3982dup (p.Asp1328fs)

dbSNP: rs1281542312
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000487366 SCV000572591 likely pathogenic not provided 2018-01-11 criteria provided, single submitter clinical testing The c.3964_3982dup19 variant causes a frameshift starting with codon Asparagine 1328, changes this amino acid to a Glycine residue and creates a premature Stop codon at position 9 of the new reading frame, denoted p.Asp1328GlyfsX9. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.3964_3982dup19 variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Although this variant has not been reported previously to our knowledge, other loss-of-function variants in the RYR1 gene have been reported in the Human Gene Mutation Database in association with RYR1-related disorders (Stenson et al., 2014).
Labcorp Genetics (formerly Invitae), Labcorp RCV001380724 SCV001578876 pathogenic RYR1-related disorder 2023-11-25 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Asp1328Glyfs*9) in the RYR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RYR1 are known to be pathogenic (PMID: 23919265, 25960145, 28818389, 30611313). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 422979). For these reasons, this variant has been classified as Pathogenic.
Revvity Omics, Revvity RCV000487366 SCV002019110 likely pathogenic not provided 2019-02-20 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002481528 SCV002791329 likely pathogenic Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome 2021-12-05 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.